S&P 500   3,798.30 (-1.33%)
DOW   30,636.62 (-0.97%)
QQQ   324.22 (-1.33%)
AAPL   143.15 (+-0.01%)
MSFT   235.57 (+1.39%)
FB   276.00 (-2.15%)
GOOGL   1,838.92 (-3.62%)
AMZN   3,285.13 (-1.23%)
TSLA   881.01 (-0.24%)
NVDA   522.23 (-2.82%)
BABA   262.31 (-1.36%)
CGC   38.40 (+8.11%)
GE   10.82 (-4.16%)
MU   76.84 (-3.36%)
AMD   91.78 (-3.09%)
NIO   58.05 (-3.75%)
T   29.60 (-0.50%)
F   10.79 (-3.57%)
ACB   11.21 (+5.06%)
BA   194.69 (-3.65%)
DIS   164.32 (-3.09%)
NFLX   539.37 (-4.01%)
GILD   66.12 (-0.87%)
S&P 500   3,798.30 (-1.33%)
DOW   30,636.62 (-0.97%)
QQQ   324.22 (-1.33%)
AAPL   143.15 (+-0.01%)
MSFT   235.57 (+1.39%)
FB   276.00 (-2.15%)
GOOGL   1,838.92 (-3.62%)
AMZN   3,285.13 (-1.23%)
TSLA   881.01 (-0.24%)
NVDA   522.23 (-2.82%)
BABA   262.31 (-1.36%)
CGC   38.40 (+8.11%)
GE   10.82 (-4.16%)
MU   76.84 (-3.36%)
AMD   91.78 (-3.09%)
NIO   58.05 (-3.75%)
T   29.60 (-0.50%)
F   10.79 (-3.57%)
ACB   11.21 (+5.06%)
BA   194.69 (-3.65%)
DIS   164.32 (-3.09%)
NFLX   539.37 (-4.01%)
GILD   66.12 (-0.87%)
S&P 500   3,798.30 (-1.33%)
DOW   30,636.62 (-0.97%)
QQQ   324.22 (-1.33%)
AAPL   143.15 (+-0.01%)
MSFT   235.57 (+1.39%)
FB   276.00 (-2.15%)
GOOGL   1,838.92 (-3.62%)
AMZN   3,285.13 (-1.23%)
TSLA   881.01 (-0.24%)
NVDA   522.23 (-2.82%)
BABA   262.31 (-1.36%)
CGC   38.40 (+8.11%)
GE   10.82 (-4.16%)
MU   76.84 (-3.36%)
AMD   91.78 (-3.09%)
NIO   58.05 (-3.75%)
T   29.60 (-0.50%)
F   10.79 (-3.57%)
ACB   11.21 (+5.06%)
BA   194.69 (-3.65%)
DIS   164.32 (-3.09%)
NFLX   539.37 (-4.01%)
GILD   66.12 (-0.87%)
S&P 500   3,798.30 (-1.33%)
DOW   30,636.62 (-0.97%)
QQQ   324.22 (-1.33%)
AAPL   143.15 (+-0.01%)
MSFT   235.57 (+1.39%)
FB   276.00 (-2.15%)
GOOGL   1,838.92 (-3.62%)
AMZN   3,285.13 (-1.23%)
TSLA   881.01 (-0.24%)
NVDA   522.23 (-2.82%)
BABA   262.31 (-1.36%)
CGC   38.40 (+8.11%)
GE   10.82 (-4.16%)
MU   76.84 (-3.36%)
AMD   91.78 (-3.09%)
NIO   58.05 (-3.75%)
T   29.60 (-0.50%)
F   10.79 (-3.57%)
ACB   11.21 (+5.06%)
BA   194.69 (-3.65%)
DIS   164.32 (-3.09%)
NFLX   539.37 (-4.01%)
GILD   66.12 (-0.87%)
Log in
NYSEARCA:LDRS

Innovator IBD ETF Leaders ETF Stock Forecast, Price & News

$28.96
-0.05 (-0.17 %)
(As of 01/27/2021 10:03 AM ET)
Add
Today's Range
$28.96
Now: $28.96▼
$28.96
50-Day Range
$28.49
MA: $28.78▼
$29.05
52-Week Range
$16.09
Now: $28.96▼
$29.53
Volume300 shs
Average Volume2,048 shs
Market Capitalization$13.03 million
P/E RatioN/A
Dividend Yield0.66%
BetaN/A

Geographic Exposure of LDRS

Currency Exposure of LDRS

Sector Exposure of LDRS

Industry Exposure of LDRS


Basic Details

Issuer Innovator Capital Management
Fund NameInnovator IBD ETF Leaders ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:LDRS
Inception Date12/21/2017
Fund ManagerDustin Lewellyn, Ernesto Tong, Anand Desai
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkIBD ETF Leaders Index
CategoryStrategy
FocusAlpha-Seeking
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$8.85 million
Average Daily Volume$1,961.70
Discount/Premium-0.01%

ETF Expenses

Management Fee0.60%
Other Expenses0.56%
Total Expenses1.16%
Fee Waiver0.00%
Net Expenses1.16%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorInnovator Capital Management, LLC
CustodianU.S. Bank, N.A.
DistributorForeside Fund Services, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market MakerVirtu Financial
$28.96
-0.05 (-0.17 %)
(As of 01/27/2021 10:03 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive LDRS News and Ratings via Email

Sign-up to receive the latest news and ratings for LDRS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Innovator IBD ETF Leaders ETF (NYSEARCA:LDRS) Frequently Asked Questions

How has Innovator IBD ETF Leaders ETF's stock been impacted by Coronavirus (COVID-19)?

Innovator IBD ETF Leaders ETF's stock was trading at $19.63 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LDRS stock has increased by 47.5% and is now trading at $28.96.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Innovator IBD ETF Leaders ETF?

Wall Street analysts have given Innovator IBD ETF Leaders ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Innovator IBD ETF Leaders ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Is Innovator IBD ETF Leaders ETF a good dividend stock?

Innovator IBD ETF Leaders ETF pays an annual dividend of $0.19 per share and currently has a dividend yield of 0.66%.
View Innovator IBD ETF Leaders ETF's dividend history.

What is Innovator IBD ETF Leaders ETF's stock symbol?

Innovator IBD ETF Leaders ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "LDRS."

How do I buy shares of Innovator IBD ETF Leaders ETF?

Shares of LDRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Innovator IBD ETF Leaders ETF's stock price today?

One share of LDRS stock can currently be purchased for approximately $28.96.

How big of a company is Innovator IBD ETF Leaders ETF?

Innovator IBD ETF Leaders ETF has a market capitalization of $13.03 million.

This page was last updated on 1/27/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.